Smart Vitamins

What Smart Vitamins does

Smart Vitamins is a privately held Spanish biotechnology company founded in 2020 as a spin-off of the University of Santiago de Compostela, headquartered at the university's Campus Vida in Santiago de Compostela. The company commercializes SDN Technology™ (Smart Delivery of Nutrients Technology), a proprietary nanocarrier/nanocapsule platform developed in the laboratory of co-founder and CSO María José Alonso. The platform is designed to multiply the bioavailability of bioactive compounds, enable controlled release, and support multiple administration routes including oral, topical, intranasal, subcutaneous, and intravenous, with claimed GMP-compatible scalable manufacturing. Smart Vitamins targets three end-markets: pharmaceutical (with proprietary research programs in autoimmune diseases and respiratory infections), cosmetic, and nutraceutical.

The company is pre-revenue and operates in an R&D phase. Its go-to-market model is B2B-oriented, intending to supply SDN Technology as licensed formulations, active ingredients, or white-label solutions to downstream pharmaceutical, cosmetic, and nutraceutical manufacturers. Its lead proprietary asset is an intranasal flu prevention therapy that demonstrated 100% prevention efficacy in preclinical rodent tests and is scheduled to enter first-in-human clinical trials in the UK in early 2026, financed by a €2.1 million funding round closed in 2025. A second program, a COVID-19 treatment, entered preclinical development in 2024 in collaboration with the University of Santiago de Compostela and the Instituto de Investigación Sanitaria de Santiago de Compostela. The company is supported by the Galician regional innovation ecosystem (IGAPE, GAIN, SILO Acelera Bio, Business Factory Food) and operates with a 1-10 employee headcount.

Name

Smart Vitamins

Legal name

Smart Vitamins S.L.

Website

https://smartvitamins.org

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Smart Vitamins is a Spanish biotech spin-off of the University of Santiago de Compostela commercializing the proprietary SDN Technology™ nanocarrier platform for delivering drugs, vitamins, and active ingredients to pharmaceutical, cosmetic, and nutraceutical industry partners.

Ownership category

akta.pro rank

Product category

Biotechnology / Drug Delivery

NAICS

Pharmaceutical Preparation Manufacturing (325412), Research and Development in Nanotechnology (541713)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Vitamins (A, B-Complex, C, D, E, K; Premixes) (AFAJAKAA)

akta.pro secondary industry

Nasal Drug Delivery Devices (Sprays/Powder Devices) (HLAHAIAK)

Keywords

• Drug delivery systems
• Nanocarrier formulations
• Pharmaceutical biotechnology
• Nutraceutical development
• Cosmetic formulations

Headquarters

HQ city

Santiago De Compostela

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Core offering

Smart Vitamins develops the SDN Technology™ platform, a nanocarrier-based delivery system enabling precise administration of drugs, vitamins, and essential nutrients across oral, topical, intranasal, subcutaneous, and intravenous routes. The company applies this technology to create proprietary formulations for the pharmaceutical, cosmetic, and nutraceutical industries, with active research programs in autoimmune diseases and respiratory infections including an intranasal flu prevention therapy and a COVID-19 treatment. Products are offered to industry partners as licensed formulations, active ingredients, or white-label solutions.

Product overview

Smart Vitamins is a biotechnology Spin Off of the University of Santiago de Compostela that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors. The company's core offering is the SDN Technology™ (Smart Delivery of Nutrients Technology) platform, a versatile nanovehicle-based system that enables the controlled and targeted delivery of bioactive compounds and molecules. Smart Vitamins applies this technology to develop proprietary research programs in autoimmune diseases and respiratory infections, including an intranasal flu prevention therapy currently in clinical trial preparation and a COVID-19 treatment in preclinical development.

Differentiator

Problem solved

Functional benefit

Brands

• SDN Technology™: Smart Delivery of Nutrients Technology platform that allows the administration of drugs, vitamins, and essential nutrients through intelligent nanovehicles for treating autoimmune and viral diseases.

Products and services

• SDN Technology™ (Smart Delivery of Nutrients Technology) A versatile nanocarrier-based delivery platform that enables precise administration of pharmaceutical drugs, vitamins, nutrients, and active ingredients across multiple routes (oral, topical, intranasal, subcutaneous, intravenous). Multiplies bioavailability, enables controlled release, and is scalable for GMP-compliant manufacturing. Offered to industry partners as licensed formulations, active ingredients, or white-label solutions.
• Intranasal Flu Prevention Therapy An intranasal influenza prevention therapy developed using the SDN Technology™ platform; demonstrated 100% efficacy in preclinical rodent studies and advancing toward first-in-human clinical trials in the UK in early 2026. Targeted at pharmaceutical partners and public health programs for flu prevention.
• COVID-19 Treatment (Nanodecov Project) A COVID-19 treatment candidate developed using SDN Technology™ in collaboration with the University of Santiago de Compostela and IIS Santiago, currently in preclinical development and being advanced toward clinical phase under the Nanodecov project. Targeted at pharmaceutical partners for respiratory infection therapeutics.

Quantifiable outcome

• 100% flu prevention rate in preclinical rodent tests
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Four partnerships are on record, tiered core, supporting and minor.

• University of Santiago de CompostelacoreStrategic or Co-development PartnerThe company is a Spin Off of the University of Santiago de Compostela, conducting joint research programs in autoimmune diseases and respiratory infections. The SDN Technology was developed by the University's Laboratory of Maria Jose Alonso.
• Instituto de Investigación Sanitaria de Santiago de CompostelacoreStrategic or Co-development PartnerCollaborative research partner for COVID-19 treatment development and other therapeutic programs. Foundation institute conducting public health research in Galicia.
• SILO Acelera BiosupportingStrategic or Co-development PartnerAccelerator program for biotechnology companies that Smart Vitamins completed, gaining innovation support and mentorship.
• Business Factory FoodminorStrategic or Co-development PartnerFood industry accelerator program where Smart Vitamins developed bioactive nanocapsules applications for the food sector.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Nanoform Finland: Finland-based nanotech drug delivery company commercializing nano-formulated active ingredients for pharmaceutical partners via proprietary CESS technology. Closest comparable to Smart Vitamins given its nanocarrier platform focus and B2B licensing business model, though it is at a more advanced commercial stage.
• Ascendia Pharmaceuticals: US-based nanoformulation CDMO offering formulation development and manufacturing for poorly soluble drugs across multiple routes. Comparable as a nanoformulation platform serving pharma partners, though Smart Vitamins is more asset-focused and Ascendia is more service-oriented.
• Camurus: Swedish specialty pharma company built on a proprietary nanocarrier FluidCrystal technology for sustained-release drug delivery across multiple administration routes. Directly comparable in technology class, route versatility, and pharma/cross-vertical applicability, though larger and publicly listed.

Emerging players

• NanoCarrier: Japanese clinical-stage nanomedicine company developing micellar nanoparticle and nucleic acid delivery technologies for oncology and infectious diseases. Comparable technology class with broader therapeutic ambition than Smart Vitamins' current pipeline.
• Ardena: European nanomedicine CDMO with formulation development and GMP manufacturing capabilities for nanopharmaceuticals. Comparable to Smart Vitamins on the formulation/manufacturing axis and European footprint, though broader in service scope.
• Selecta Biosciences: US clinical-stage biotech using synthetic nanoparticle technology for immunomodulation and tolerogenic therapies, including immune-mediated diseases. Overlaps with Smart Vitamins on nanoparticle delivery and autoimmune indications, though at a more advanced stage with broader pipeline.
• Codiak BioSciences: US biotech developing engineered exosome-based therapeutics for delivery of biologic cargo, with programs in oncology and rare diseases. Comparable in platform-engineering approach and B2B licensing optionality, though based on a different delivery vehicle (exosomes vs. nanocapsules).

Broad incumbents

• Nanobiotix: French clinical-stage nanomedicine company developing nano-enabled therapies, primarily in oncology, with a more mature clinical pipeline. Comparable in proprietary nanoplatform approach but larger, more advanced, and concentrated in oncology rather than respiratory/autoimmune indications.

Regional players

• Laboratorios Farmaceuticos Rovi: Spanish specialty pharma company with capabilities across injectable drug delivery and formulation, including partnerships and in-licensing of innovative delivery technologies. Comparable as a Spanish/Iberian pharma player that could plausibly partner with or acquire a local nanocarrier platform like Smart Vitamins.

Others

• BIND Therapeutics: Pioneering nanoparticle drug delivery platform (Accurins) acquired by Pfizer; representative of the nanoparticle-delivery competitive set Smart Vitamins would face for partnerships and M&A.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/smart-vitamins-sl

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smart Vitamins